Andra AP-fonden’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.59M | Buy |
+8,840
| New | +$2.91M | 0.03% | 324 |
|
|
2025
Q2 | – | Sell |
-13,500
| Closed | -$5.87M | – | 482 |
|
|
2025
Q1 | $5.87M | Sell |
13,500
-52,500
| -80% | -$21.1M | 0.1% | 269 |
|
|
2024
Q4 | $24.3M | Buy |
66,000
+10,100
| +18% | +$4.23M | 0.39% | 76 |
|
|
2024
Q3 | $29.1M | Buy |
55,900
+3,000
| +6% | +$1.6M | 0.43% | 65 |
|
|
2024
Q2 | $28.7M | Sell |
52,900
-6,500
| -11% | -$3.44M | 0.48% | 50 |
|
|
2024
Q1 | $30.8M | Buy |
+59,400
| New | +$29.5M | 0.55% | 46 |
|
|
2023
Q3 | – | Sell |
-23,900
| Closed | -$10.6M | – | 364 |
|
|
2023
Q2 | $10.6M | Buy |
23,900
+7,100
| +42% | +$3.28M | 0.27% | 83 |
|
|
2023
Q1 | $7.72M | Sell |
16,800
-2,800
| -14% | -$1.33M | 0.2% | 212 |
|
|
2022
Q4 | $10.1M | Sell |
19,600
-7,900
| -29% | -$4.01M | 0.3% | 54 |
|
|
2022
Q3 | $12.5M | Sell |
27,500
-2,400
| -8% | -$1.15M | 0.41% | 18 |
|
|
2022
Q2 | $14.4M | Buy |
+29,900
| New | +$14.8M | 0.41% | 15 |
|
|
2021
Q4 | $15.7M | Sell |
33,800
-600
| -2% | -$252K | 0.32% | 54 |
|
|
2021
Q3 | $12.8M | Sell |
34,400
-100
| -0.3% | -$38K | 0.26% | 96 |
|
|
2021
Q2 | $13.2M | Sell |
34,500
-700
| -2% | -$268K | 0.27% | 80 |
|
|
2021
Q1 | $12.6M | Sell |
35,200
-100
| -0.3% | -$32.2K | 0.28% | 63 |
|
|
2020
Q4 | $11.3M | Buy |
35,300
+11,900
| +51% | +$3.65M | 0.25% | 95 |
|
|
2020
Q3 | $6.29M | Sell |
23,400
-1,900
| -8% | -$511K | 0.17% | 268 |
|
|
2020
Q2 | $6.65M | Sell |
25,300
-5,200
| -17% | -$1.39M | 0.19% | 175 |
|
|
2020
Q1 | $6.92M | Buy |
30,500
+500
| +2% | +$136K | 0.25% | 37 |
|
|
2019
Q4 | $9.06M | Sell |
30,000
-1,400
| -4% | -$385K | 0.26% | 22 |
|
|
2019
Q3 | $7.54M | Sell |
31,400
-2,700
| -8% | -$740K | 0.22% | 77 |
|
|
2019
Q2 | $9.62M | Sell |
34,100
-1,700
| -5% | -$464K | 0.28% | 11 |
|
|
2019
Q1 | $10.3M | Buy |
+35,800
| New | +$10.4M | 0.3% | 8 |
|
|
2018
Q3 | $10.1M | Buy |
36,800
+800
| +2% | +$208K | 0.26% | 52 |
|
|
2018
Q2 | $8.57M | Sell |
36,000
-600
| -2% | -$139K | 0.23% | 100 |
|
|
2018
Q1 | $8.04M | Sell |
36,600
-4,100
| -10% | -$963K | 0.21% | 129 |
|
|
2017
Q4 | $9.16M | Sell |
40,700
-6,100
| -13% | -$1.3M | 0.21% | 140 |
|
|
2017
Q3 | $8.89M | Buy |
46,800
+4,900
| +12% | +$933K | 0.21% | 140 |
|
|
2017
Q2 | $7.88M | Buy |
41,900
+800
| +2% | +$144K | 0.2% | 141 |
|
|
2017
Q1 | $6.8K | Buy |
41,100
+3,400
| +9% | +$541K | 0.16% | 168 |
|
|
2016
Q4 | $5.42M | Sell |
37,700
-7,500
| -17% | -$1M | 0.15% | 202 |
|
|
2016
Q3 | $5.66M | Sell |
45,200
-2,400
| -5% | -$310K | 0.15% | 192 |
|
|
2016
Q2 | $6.25M | Sell |
47,600
-3,700
| -7% | -$506K | 0.16% | 166 |
|
|
2016
Q1 | $7.13M | Sell |
51,300
-9,600
| -16% | -$1.28M | 0.19% | 143 |
|
|
2015
Q4 | $8.49M | Buy |
60,900
+18,000
| +42% | +$2.48M | 0.24% | 114 |
|
|
2015
Q3 | $6.01M | Sell |
42,900
-900
| -2% | -$135K | 0.18% | 148 |
|
|
2015
Q2 | $7.19M | Buy |
43,800
+2,300
| +6% | +$367K | 0.21% | 140 |
|
|
2015
Q1 | $6.41M | Buy |
+41,500
| New | +$5.91M | 0.18% | 152 |
|
|
2014
Q4 | – | Sell |
-50,600
| Closed | -$6.05M | – | 592 |
|
|
2014
Q3 | $6.05M | Sell |
50,600
-43,900
| -46% | -$5.04M | 0.14% | 223 |
|
|
2014
Q2 | $10.2M | Sell |
94,500
-34,400
| -27% | -$3.54M | 0.22% | 139 |
|
|
2014
Q1 | $12.8M | Buy |
128,900
+15,600
| +14% | +$1.41M | 0.3% | 87 |
|
|
2013
Q4 | $10.5M | Buy |
113,300
+9,900
| +10% | +$880K | 0.25% | 111 |
|
|
2013
Q3 | $8.64M | Buy |
103,400
+32,300
| +45% | +$2.77M | 0.22% | 139 |
|
|
2013
Q2 | $5.82M | Buy |
+71,100
| New | +$5.32M | 0.15% | 235 |
|
Other funds holding ELV
VCM
VPM
Andra AP-fonden's ELV Position: Q1 2026 in Review
Andra AP-fonden opened a new position in Elevance Health (ELV) in Q1 2026: 8,840 shares worth $2.59M. The stake represents 0.03% of the portfolio and ranks #324 among its holdings. This is a return to the name: Andra AP-fonden previously reported a position in ELV as recently as Q1 2025.
Andra AP-fonden first reported a position in ELV in Q2 2013 and has held it in 44 quarters since. The position peaked at $30.8M in Q1 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Andra AP-fonden held 8,840 shares of Elevance Health worth $2.59M as of Q1 2026.
- Elevance Health was a new Andra AP-fonden position in Q1 2026.
- Elevance Health made up 0.03% of Andra AP-fonden's portfolio in Q1 2026, its #324 holding.
- Andra AP-fonden first reported a position in Elevance Health in Q2 2013 and has held it in 44 quarters since.
- Andra AP-fonden's Elevance Health position peaked at $30.8M in Q1 2024.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.